Buy-side firms urged to avoid stampede to CCPs

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Buy-side firms should begin testing over-the-counter derivatives clearing services as early as possible to avoid getting trampled in a last-minute stampede, according to senior industry participants at a recent webinar hosted by Risk in New York.

Under the Dodd-Frank Act, standardised OTC derivatives will be required to be traded on swap execution facilities and cleared through central counterparties (CCPs). Regulators are going through a lengthy process of rule-making to implement the changes

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]